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Baroreceptor refl ex sensitivity (BRS) has been found lower and heart 
rate variability (HRV) parasympathetic markers have been found 
higher in healthy women than in healthy men. Thus, in the present 
study we hypothesized gender diﬀ erences in the autonomic func-
tion among hypertensive subjects. Forty–one hypertensive patients 
and 34 normotensive subjects, age 53 ± 1 years, were examined. Four 
weeks aft er cessation of antihypertensive therapy, HRV was assessed 
in 24–hour Holter ECGs, and BRS was calculated with the transfer 
technique. A t test was performed aft er log transformation of spectral 
values. Resting blood pressure and heart rate in the hypertensive and 
the normotensive groups were 150 ± 2/100 ± 1 (mean ± SEM) and 121 ± 
2/81 ± 1 mmHg, respectively, and 68 ± 1 and 60 ± 1 bpm, respectively 
(P<0.0005). Compared with normotensive controls, hypertensive pa-
tients had lower total power (1224 ± 116 versus 1797 ± 241 ms2; P=0.03), 
lower low frequency power (550 ± 57 versus 813 ± 115 ms2; P=0.04), low-
er high frequency power (141 ± 23 versus 215 ± 38 ms2; P=0.06), lower 
root mean square successive diﬀ erence (28.7 ± 2.7 versus 35.7 ± 3.0 ms; 
P=0.03), and PNN50 (4.9 ± 0.6% versus 9.8 ± 1.5%; P=0.003). BRS was 
also lower in the hypertensive subjects (7.6 ± 0.6 versus 10.4 ± 0.8 ms/
mmHg; P=0.005). When comparing the same parameters between nor-
motensive subjects and hypertensive subjects within the same gender 
group, we found signifi cant reduction (P<0.05) only within the female 
group. The diﬀ erence in BRS within the female group was twice that 
within the male group. Stepwise multiple regression analysis revealed 
gender, age, HDL cholesterol, and blood pressure as independent ex-
planatory variables of BRS and HRV. Our results suggest that gender 
is an important determinant of BRS and HRV. Autonomic function pa-
rameters were especially impaired in hypertensive women compared 
with hypertensive men.
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Introduction
The autonomic nervous system plays a crucial role in blood pressure 
(BP) and heart rate (HR) control and may thus be an important patho-
physiological factor in the devel opment of hypertension. There have 
been numerous studies on plasma catecholamines in essential hyper-
tension,1 most of which have shown increased levels in hypertensive 
subjects. Moreover, disturbed autonomic HR and BP control has been 
demonstrated in several studies by means of HR variability (HRV) and 
baroreceptor refl ex sensitivity (BRS).2–10 
HRV, which estimates the tonic HR control,11–13 is gener ally reduced 
(standard deviation of all R–R intervals [SDNN] and total power [en-
ergy in the heart period spectrum between 0.0033 and 0.40 Hz] [TP]) 
in hypertensive patients.2,4–6 Markers of sympathetic predominance are 
increased in some3 but not all studies.4–6 
BRS, which estimates the refl ex vagal HR control,11–13 is reduced in 
hypertensive subjects.6–10 Both BRS and HRV parameters (except low 
frequency power [energy in the heart period spectrum between 0.04 
and 0.15 Hz] [LF]/high fre quency power [energy in the heart period 
spectrum between 0.15 and 0.40 Hz] [HF]) decrease with increasing age 
in healthy10,14 and hypertensive subjects.10 It is also proposed that BRS 
stabilizes aft er middle age.8 
There may be gender diﬀ erences in the pathophysiology of essential 
hypertension. We have previously observed that hypertensive women 
have low–renin hypertension15 and less cardiovascular reactivity to 
stress compared with hyperten sive men.16 However, thus far there has 
been only 1 specifi c study on possible gender diﬀ erences in HRV in 
hypertension,4 and there have been none on BRS. Singh et al4 found 
reduced LF/HF ratio but not TP, percentage of adjacent R–R intervals 
diﬀ ering >50 ms (PNN50), square root of the mean of the sum of the 
squares of diﬀ erences between adjacent R–R intervals (RMSSD), LF, 
and HF in hypertensive women compared with hypertensive men. 
However, there are more studies on gender diﬀ erences in healthy 
subjects. SDNN,4,17,18 LF/HF ratio, and LF normal ized units [LF/
(LF+HF)×100]4,17,19 have been found lower and HF normalized units 
[HF/(LF+HF)×100]17 and HF4,17,19 have been found higher in women than 
in men. Moreover, BRS is reduced in women compared with men,14,17,18,20 
but the diﬀ erence is not signifi cant in those age ≥60 years.14 
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In both healthy and hypertensive subjects, previous studies suggest 
a higher tonic parasympathetic activity in women than in men. Sur-
prisingly, these studies also propose decreased refl ex vagal responses 
in healthy women compared with healthy men. However, the correla-
tion between HRV and BRS is weak.12 
While gender diﬀ erences in HRV and BRS have been studied in 
healthy subjects, no one has addressed specifi cally gender diﬀ erences 
in BRS in hypertensive patients compared with normotensive controls. 
This article presents some new fi ndings suggesting that autonomic 
dysfunction may play a more prom inent role in female than in male 
hypertension. 
Methods
Subjects. Patients were eligible if they were age >18 years and suﬀ ered 
from mild to moderate hypertension (systolic BP≥140 and ≤180 mmHg, 
diastolic BP≥90 mmHg). Patients were excluded if secondary hyperten-
sion was suspected, if they had recently suﬀ ered from a cardiovascular 
event, if organ failure was present, or if they had diabetes mellitus, 
autoimmune disease, or Parkinson’s disease. Use of neuroleptics, an-
tidepressants, lithium, antiarrhythmics, and cime tidine was not al-
lowed. These criteria were similar for the normo tensive controls except 
for their BP level, which had to be <140/90 mmHg. 
Patients were recruited from the outpatient clinic for hypertensive 
patients, Ullevål University Hospital, Oslo, Norway, and the Univer-
sity Hospital of Groningen, Netherlands. Normotensive controls were 
partly former participants in a screening program for cardiovascular 
Table 1. Basal Characteristics in Normotensive vs Hypertensive Subjects 
Basal Parameters  Normotensive  Hypertensive  P 
n  34  41  
Age, y  52.7 ± 1.5  52.1 ± 1.4  NS 
BMI, kg/m2  26.5 ± 0.6  26.9 ± 0.5  NS 
Smoker, %  23.5  26.8  NS 
Hematocrit, fraction  0.40 ± 0.005  0.41 ± 0.006  NS 
Creatinine, µmol/L  84.0 ± 2.4  81.0 ± 2.1  NS 
Total cholesterol, mmol/L  5.8 ± 0.8  5.6 ± 0.3  NS 
HDL cholesterol, mmol/L  1.2 ± 0.06  1.5 ± 0.09  0.02 
Triglyceride, mmol/L  1.2 ± 0.1  1.3 ± 0.2  NS 
Systolic BP, mmHg  121 ± 2  150 ± 2  <0.0005 
Diastolic BP, mmHg  81 ± 1  100 ± 1  <0.0005 
HR, bpm  60 ± 1  68 ± 1  <0.0005 
Data are mean ± SEM.
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risk factors. The subjects entered the study between September 1996 
and February 1999. All patients gave wriĴ en informed consent. The 
regional ethical research commiĴ ees in both countries approved the 
protocol. Baseline characteristics at inclusion are summarized in Tables 
1 and 2.
Study Procedure. All subjects were examined at 2 visits. At the fi rst visit, 
patients were advised to stop taking any antihypertensive drugs. The pa-
tients who terminated antihypertensive medication were scheduled for 
BP control once a week aft er the fi rst visit. At 4 weeks aft er the fi rst visit, 
the second visit, the fi nal assessment of eligibility, was performed. 
All examinations were performed in the morning in a quiet room with 
temperature 22°C to 24°C. The subjects were examined aft er an overnight 
fast and had refrained from alcohol and tobacco for at least the last 24 
hours. HR and siĴ ing sphygmomanometric BP were measured aft er 10 
minutes of rest. Beat–to–beat BP and HR were recorded with the patient 
in the supine position with a Finapres (Ohmeda 2300) noninva sive BP 
monitor with the appropriate cuﬀ  applied to the third fi nger of the left  
hand. This instrument has been validated, and the accuracy and preci-
sion have been found suﬃ  cient for tracking of changes in BP and HR.21 A 
24–hour Holter ECG was applied to the chest (MarqueĴ e series 8500). 
Because mental stress can infl uence autonomic functions, the pur-
pose of visit 1 was to familiarize the patient with the study procedure. 
Thus, only data from the second visit are presented. 
Table 2. Basal Characteristics in Normotensive Women vs Hypertensive Women
and Normotensive Men vs Hypertensive Men 
  Female    Male 
Basal Parameters  Normotensive  Hypertensive  P  Normotensive  Hypertensive  P 
n  15  17   19  24  
Age, y  51.4 ± 1.2  54.6 ± 1.5  NS  53.6 ± 2.6  50.3 ± 2.1  NS 
BMI, kg/m2  26.6 ± 1.1  28.3 ± 0.9  NS  26.4 ± 0.6  25.9 ± 0.6  NS 
Smoker, %  33.3  11.8  NS  15.8  37.5  NS 
Hematocrit, fraction  0.38 ± 0.008  0.39 ± 0.008  NS  0.42 ± 0.005  0.43 ± 0.005  NS 
Creatinine, µmol/L  74.1 ± 2.3  70.8 ± 2.2  NS  91.9 ± 2.9  88.5 ± 2.2  NS 
Total cholesterol, mmol/L  5.7 ± 0.3  6.0 ± 0.5  NS  5.8 ± 0.3  5.2 ± 0.3  NS 
HDL cholesterol, mmol/L  1.5 ± 0.08  1.6 ± 0.2  NS  1.1 ± 0.07  1.4 ± 0.09  0.004 
Triglyceride, µmol/L  1.1 ± 0.2  1.4 ± 0.3  NS  1.2 ± 0.1  1.3 ± 0.3  NS 
Systolic BP, mmHg  121 ± 2  149 ± 2  <0.0005  121 ± 2  151 ± 3  <0.0005 
Diastolic BP, mmHg  81 ± 1  99 ± 1  <0.0005  81 ± 1  100 ± 1  <0.0005 
HR, bpm  60 ± 1  69 ± 2  0.009  60 ± 1  67 ± 2  <0.0005 
Data are mean ± SEM. 
Sevre et al 
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HRV Analysis. Twenty–four– hour ambulatory ECG recordings were 
analyzed on a MarqueĴ e laser Holter system (series 8000XP). HRV was 
analyzed as described previously22 and in accordance with interna-
tional guidelines.23 Three ECG leads (modifi ed leads V1,V5, and aVF) 
and a time signal to correct for tape speed irregularities were recorded. 
The 24–hour recordings were divided into 288 segments of 5 minutes. 
Twelve 5–minute segments were averaged to obtain hourly mean val-
ues of the HRV parameters. All ectopic beats were classifi ed, and only 
segments with 15% ectopy were used. Each nonnormal R–R interval 
was substituted by the subsequent R–R interval. Two experienced 
Holter analysts, with supervision of a cardiologist, analyzed all record-
ings. Normalized units, TP, LF, and HF have been defi ned previously 
in this report. 
BRS Measurement. Finapres recordings of 8 segments of 300 seconds 
of beat–to–beat BP and HR during rest in the supine position were 
used for determina tion of the BRS with the CARSPAN program (Pro-
GAMMA bv), as described previously.7,24,25 This program allows dis-
crete Fourier transformation of nonequidistant samples of BP and R–R 
interval series. The signals were tested for stationarity, and artifacts 
were corrected. Nonstationary signals or periods with >10% correction 
were excluded. Segments that lasted <100 seconds aft er this procedure 
were excluded. Subsequently, spectral analysis of systolic BP and R–R 
interval length was performed, and BRS was calculated by the transfer 
function method. This method defi nes the BRS as the mean modulus 
between systolic BP and R–R interval length spectra in the midfre-
quency band (0.07 to 0.14 Hz) with a coherence of >0.5. BRS is expressed 
in ms/mmHg. A BRS of 10 ms/mmHg indicates that a rise of 1 mmHg 
in systolic BP will induce 10 ms of R–R interval lengthening. 
Statistical Analysis. On the basis of previous studies,7,9 we expected 
a possible diﬀ erence in BRS of 3 ms/mmHg between normotensive 
and hypertensive subjects. With a possible SD of 3 ms/mmHg, at least 
15 patients and 15 controls should be examined with a power of 80%. 
Because we also planned a subgroup analysis based on gender diﬀ er-
ences, however, we included more than twice as many subjects in both 
groups. The data were analyzed with the use of SPSS 9.0.1 statistical 
package (SPSS Inc). Nonnormal distributed data were natural log trans-
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formed. Two–tailed statistical analyses of data were performed with 
Student’s t test (P) and Pearson’s correlation coeﬃ  cient (r). Stepwise 
multiple regression analysis was performed with gender, BP group 
(hypertensive or normotensive), age, body mass index (BMI), smoking 
status, triglyceride, and total and HDL cholesterol as predictors and 
HRV parameters and BRS as dependent variables. Data are presented 
as mean ± SEM. The level of statistical signifi  cance was set at P=0.05. 
Results 
Baroreceptor Refl ex Sensitivity. All subjects had at least 1 available 
300–second period for BRS measurement.
 
Diﬀ erences Between Hypertensive and Normotensive Subjects. BRS was re-
duced in the hypertensive patients compared with the normotensive 
controls (7.6 ± 0.6 versus 10.4 ± 0.8 ms/mmHg, respectively; P=0.005). 
Gender Diﬀ erences. Hypertensive women had lower BRS than normo-
tensive women. The diﬀ erence in BRS between male hypertensive and 
normotensive subjects did not reach statistical signifi  cance. Female hy-
pertensive subjects had lower BRS than male hypertensives. BRS did 
not diﬀ er signifi cantly between the 2 normotensive groups (Figure 1). 





Figure 1. BRS in 41 hypertensive (HT) and 34 normotensive (NT) subjects. BRS was significantly lower in the 
female hypertensive group than in the female normotensive group but did not diﬀ er sig nificantly between 
the 2 male groups. BRS was significantly lower in the female hypertensive group than in the male hyperten-









 NT females HT females NT males HT males
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groups (r=–0.65 and r=–0.61, respectively; P<0.01) but not in the female 
groups. In the female hypertensive group only, we found a signifi cant 
correlation between systolic BP and BRS (r=–0.51; P<0.04). 
Multiple Regression Analysis. Gender, age, and presence of hypertension 
were the only signifi cant independent explanatory variables of BRS. 
BRS decreased with increasing age and was lower in female and hy-
pertensive subjects than in men and normotensive subjects (Table 3). 
Heart Rate Variability. Seventy–fi ve 24–hour ECG recordings were 
analyzed. All had at least 18–hour recordings suitable for HRV analy-
sis. 
Diﬀ erences Between Hypertensive and Normotensive Subjects. PNN50, 
RMSSD, TP, LF, and HF were lower in the hyper tensive group than in 
the normotensive group. We did not fi nd any signifi cant diﬀ erences in 
normalized units or LF/HF ratio between the hypertensive and nor-
motensive subjects, although there was a nonsignifi cant tendency of 
higher LF/HF ratio in the hypertensive group (Table 4). 
Gender Diﬀ erences. Hypertensive women had higher HF normalized 
units and lower LF normalized units and LF/HF ratio than hyperten-
sive men. Similar gender diﬀ erences were found in the normotensive 
groups. The hypertensive women had signifi cantly lower TP and LF 
Table 3. Stepwise Multiple Regression With Gender, BP Group, Age, HDL Cholesterol, BMI, Total Choles-
terol, Triglyceride, and Smoking Status as Predictors and BRS, Mean R–R, SDNN, PNN50, RMSSD, TP, LF, 
HF, LF/HF Ratio, LF Normalized Units, and HF Normalized Units as Dependent Variables 
 Gender* HT or NT†  Age  HDL Cholesterol 
Dependent          
Variables  β P  β P  β P  β P  R2 
BRS, ms/mmHg  –1.8  0.03  –2.9  0.001  –0.3  <0.0005   NS  0.42 
Mean R–R, ms  –56.7  0.004  –36.6  0.04   NS  113.4  <0.0005  0.30 
SDNN, ms   NS   NS   NS  27.7  0.02  0.08 
PNN50, %  –3.2  0.03  –5.0  <0.0005  –0.3  0.001  7.1  <0.0005  0.36 
RMSSD, ms  –11.0  0.006   NS   NS  22.5  <0.0005  0.22 
TP, ms2  –897.9  <0.0005  –589.5  0.008  –51.6  <0.0005  842.0  0.006  0.32 
LF, ms2  –360.0  0.001  –279.5  0.009  –28.1  <0.0005   NS 0.35 
HF, ms2  –91.6  0.04   NS  –5.3  0.03  189.7  0.001  0.15 
LF/HF ratio   NS   NS  –0.01  0.01  –3.2  <0.0005  0.31 
LF normalized units   NS   NS   NS  –11.0  <0.0005  0.29 
HF normalized units   NS   NS   NS  11.0  <0.0005  0.29 
BMI, total cholesterol, and triglyceride were not independent explanatory variables. Smoking status was 
signifi cantly related to TP and RMSSD (P=0.03, both). Only gender, BP group, age, and HDL cholesterol 
were included in R2. 
* Male=1, female=2. 
† Normotensivecontrols (NT)=0; hypertensive patients (HT)=1. 
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than the hypertensive men (Figures 2 and 3). There were signifi cant 
diﬀ erences between hypertensive and normotensive women in the 
same parameters as seen between the entire hypertensive and entire 
normotensive group (Figures 2 and 3). We did not fi nd any signifi cant 
diﬀ erences between hyperten sive and normotensive men in any of the 
HRV parameters. 
Multiple Regression Analysis. Age, gender, HDL cholesterol, and pres-
ence of hypertension were the only signifi cant independent explanato-
ry variables of HRV numerical values, ie, the variability decreased with 
increasing age and was blunted in hypertensive subjects and women 
as opposed to normotensive subjects and men. HRV increased with 
increasing HDL concentrations. The normal ized units of HF and LF 
were only related to HDL choles terol, ie, the higher the HDL concentra-
tions were, the lower were LF normalized units and the higher were 
HF normalized units. LF/HF ratio was related to both HDL and age, ie, 
LF/HF ratio decreased with increasing HDL and age (Table 3). 
Hemoglobin, Hematocrit, Creatinine, and Blood Lipids. 
Diﬀ erences Between Hypertensive and Normotensive Subjects. HDL choles-
terol was higher in the hypertensive than in the normotensive group. 
We did not fi nd any statistically signifi cant diﬀ erences in hematocrit, 
creatinine, total cholesterol, or triglycerides (Table 1). 
Gender Diﬀ erences. Hypertensive men had higher HDL than normo-
tensive men. There were no statistically signifi cant HDL diﬀ erences 
be tween the 2 female groups. Female normotensive subjects had 
higher HDL (P<0.0005) than male normotensive subjects. Creatinine 
Table 4. HRV in Normotensive vs Hypertensive Subjects 
HRV Parameters  Normotensive  Hypertensive  P 
n  34  41  
Mean R–R, ms  836 ± 16  802 ± 12  NS 
SDNN, ms  151 ± 7  139 ± 5  NS 
PNN50, %  9.8 ± 1.5  4.9 ± 0.6  0.003 
RMSSD, ms  35.7 ± 3.0  28.7 ± 2.7  0.034 
TP, ms2  1797 ± 241  1224 ± 116  0.033 
LF, ms2  813 ± 115  550 ± 57  0.044 
HF, ms2  215 ± 38  141 ± 23  NS (0.055) 
LF/HF ratio  4.75 ± 0.36  5.34 ± 0.48  NS 
LF normalized units  80.2 ± 1.2  80.5 ± 1.4  NS 
HF normalized units  19.8 ± 1.2  19.5 ± 1.4  NS 
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Figure 2. HRV frequency domain parameters in 41 hypertensive (HT) 
and 34 normotensive (NT) subjects. TP and LF were signifi cant lower in 
hypertensive women than in normotensive women. HF was lower as well, 
but not at the level of significance. TP, LF, HF normalized units (nu), LF 
normalized units, and LF/HF ratio diﬀ ered significantly between the male 
and female hyper tensive groups. LF normalized units, HF normalized 
units, and LF/HF ratio diﬀ ered significantly between the male and female 





























Figure 3. HRV time domain parameters in 41 hypertensive (HT) and 34 
normotensive (NT) subjects. PNN50 and RMSSD were significantly lower 
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and hematocrit was higher in the male group than in the female group 
(P<0.001). We did not fi nd any gender diﬀ erences in cholesterol and 
triglyceride (Table 2). 
Discussion
The present study demonstrated signifi cantly lower BRS in hyperten-
sive subjects than in normotensive controls. More over, the reduction 
in BRS was most pronounced in the female group and did not reach 
statistical signifi cance in men. BRS was also signifi cantly reduced in 
hypertensive women compared with hypertensive men. Systolic BP 
correlated signifi cantly with BRS in the female hypertensive group 
only. 
In addition, we found signifi cantly reduced TP, LF, PNN50, and 
RMSSD in hypertensive patients compared with normoten sive con-
trols. In our subgroup analysis these diﬀ erences were only observed in 
the women and not in the men. 
LF normalized units and LF/HF ratio were higher in men than in 
women in both BP groups. By multiple regression analysis, gender, 
age, and BP were independent determinants of BRS and HRV, TP, LF, 
HF, PNN50, and RMSSD. High HDL was associated with high values 
of HRV with the exception of LF normalized units and LF/HF ratio, 
which were negatively correlated. Thus, in the present study we have 
demonstrated substantial changes in the autonomic function in hy-
pertensive patients. Moreover, autonomic dysfunction seems to play a 
more prominent role in female than in male hypertension. 
The 4 groups were well matched with respect to gender, smoking, 
BMI, and age, making our subgroup analyses feasible without any con-
founding factors. 
BRS was calculated with the transfer technique, which utilizes the 
spontaneous fl uctuations in systolic BP and HR mainly induced by the 
respiration to estimate the BRS. It does not interfere with any cardio-
vascular control mechanisms26 and correlates well with the phenyleph-
rine ramp method in healthy24 and hypertensive subjects.7 
Our BRS results confi rm the fi ndings of reduced BRS in hypertensive 
patients.6 –10 BRS did not diﬀ er between normo tensive men and women. 
This is in accordance with Laitinen et al,14 who did not fi nd any diﬀ er-
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ence between healthy postmeno pausal female subjects aged 60 to 77 
years and male age–matched subjects. 
Our fi nding of a substantial reduction of BRS, especially in female 
hypertension, warrants some comments. Rapid changes in HR follow-
ing alterations in BP are mediated by the barore ceptor refl ex arc, which 
is an important part of hemodynamic homeostasis. It has been sug-
gested that hypertension is associ ated with a reseĴ ing of the refl ex arc 
at a higher set point.27 Female sex hormones may also be important 
in modeling female arteries. The compliance of the brachial artery is 
higher in women than in men.28 Pregnant women have thinner arterial 
intima layer and thicker media layer than controls.29 Estrogen therapy 
alone or in combination with simvastatin improves fl ow–mediated 
dilation of the brachial artery.30 Interestingly, estrogen alone also in-
creases HDL cholesterol concentrations.30 These studies propose that 
female sex hormones model the arterial layers, which are crucial to 
the arterial BP buﬀ er capacity and hence blood pressure variability 
and BRS. Furthermore, estrogen replacement therapy increases BRS in 
postmenopausal healthy women.17 In our study all but 1 woman were 
postmeno pausal, and BRS did not diﬀ er signifi cantly between the male 
and the female normotensive groups. Arteriosclerotic plaques may me-
chanically cause arterial rigidity and consequently de crease BRS.8 It 
is unlikely, however, that the women in our hypertensive group have 
more arteriosclerotic changes than their male counterparts. BRS is also 
lower in hypertensive subjects with insulin resistance than in hyper-
tensive subjects with normal insulin tolerance.6 Our study lacks data 
regarding insulin resis tance, but there were no signifi cant diﬀ erences 
in BMI between the 4 groups, nor did any subjects suﬀ er from diabetes. 
For these reasons we fi nd it unlikely that diﬀ erent sex hormone concen-
trations, arteriosclerotic changes, or insulin resistance can ex plain our 
results. Moreover, the close relationship between BRS and BP only in 
hypertensive women supports the assumption that autonomic dys-
function may play a more important role in female hypertension. 
The HRV diﬀ erences between hypertensive and normoten sive sub-
jects demonstrated in the present study are in accordance with pre-
vious studies on HRV regarding the reduction in TP, HF, LF,2,4–6 and 
PNN50.2 We found a small and nonsignifi cant increase in the LF/HF 
ratio and LF normalized units in the hypertensive group compared 
with the normotensive group. This is in accordance with Pikkujamsa 
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et al6 but not with GuzzeĴ i et al,3 who demonstrated signifi cantly 
increased LF normalized units in the hypertensive group, and Hui-
kuri et al,5 who dis played decreased LF/HF ratio in the hypertensive 
group. Our subjects were examined twice, whereas GuzzeĴ i et al only 
examined their subjects once. This may explain the diverging results. 
Most probably, the responses to the laboratory exami nation per se will 
diﬀ er between the fi rst and second examinations.31 The subjects in 
the study by Huikuri et al5 were using vasoactive drugs at the time 
of the examination, which may have infl uenced the results. As dem-
onstrated by other investigators4,17,19 we found higher PNN50, LF/HF 
ratio, and LF nor malized units in male normotensives than in female 
normoten sives. We also confi rmed the results of Singh et al4 regarding 
PNN50, RMSSD, and LF/HF ratio in hypertensive men com pared with 
hypertensive women, but, in contrast, we did not fi nd any signifi cant 
HRV discrepancies between the male hyperten sive and normotensive 
groups. The probability of type II errors should be considered. 
The reduction of overall HRV in hypertensive patients is more pro-
nounced in women than in men. On the other hand, the relative HRV 
parameters, ie, normalized units and the LF/HF ratio, did not reveal 
any signifi cant diﬀ erences between the normotensive and hypertensive 
subjects in either the male or the female group. We can only speculate 
as to possible explanations of these results. One interpretation could be 
a generally more pronounced withdrawal of autonomic HR control in 
hyperten sive women than in hypertensive men, even though the bal-
ance between the sympathetic and parasympathetic nervous system 
is similar. This assumption is further supported by the BRS results, 
which suggest less HR responsiveness to changes in systolic BP in hy-
pertensive women compared with hypertensive men and normoten-
sive subjects. 
During the past decade, BRS has proven to be a powerful indepen-
dent marker of increased risk for malignant cardiac arrhythmias and 
sudden death aft er myocardial infarction.12,32 HRV measurements have 
also been investigated as predictors of cardiovascular morbidity. How-
ever the results have been diverg ing. While TP,33 ultra low frequency 
power,33 very low fre quency power,33 and SDNN32 have proven to be 
independent markers of cardiovascular morbidity, the results regard-
ing HF and LF have been less convincing.33 We still lack a physiolog ical 
understanding of the former HRV parameters, beyond that they refl ect 
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a general variability.23,33 Conversely, the physiolog ical basis for the lat-
ter is beĴ er understood.23 
On the basis of reports in patients with other kinds of cardiovascular 
diseases,12,32,33 however, we might anticipate an association between low 
BRS and reduced HRV with cardio vascular morbidity in hypertensive 
subjects as well. On the basis of these considerations, our fi ndings may 
imply that hyperten sive women are more susceptible to cardiac events 
and arrhyth mias than hypertensive men. No long–term studies, how-
ever, have been performed to investigate this possibility. 
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